1National Comprehensive Cancer Network.NCCN clinical practice guidelines in oncology:cancer-and chemotherapy-induced anemia.2010,V.2[J/OL].2010(2010-08-01).http://www.nccn.org/index.asp.
2Rizzo JD,Somerfield MR,Hagerty KL,et al.Use of epoetin and darbepoetin in patients with cancer:2007 American Society of Clinical Ontology/American Society of Hematology Clinical Practice Guideline Update[J].J Clin Oncol,2008,26(1):132-149.
3Groopman JE,Itri LM.Chemotherapy-induced anemia in adults:incidence and treatment[J].J Natl Cancer Inst,1999,91:1616-1634.
4Del Mastro L,Gennari A,Donati S.Chemotherapy of non-smallcell lung cancer:role of erythropoietin in the management of anemia[J].Ann Oncel,1999,10(Suppl 5):91-94.
5Birgegard G,Aapro MS,Bokemeyer C,et al.Cancer-related anemia:pathogenesis,prevalence and treatment[J].Oncology,2005,68(Suppl 1):3-11.
6Ludwig H,Van Belle S,Barrett-Lee P,et al.The European Cancer Anaemia Survey(ECAS):A large,multinational,prospective survey defining the prevalence,incidence,and treatment of anaemia in cancer patients[J].Eur J Cancer,2004,40(15):2293 2306.
7Miller CB,Jones RJ,Piantadosi S,et al.Decreased erythropoietin response in patients with the anemia of cancer[J].N Eng J Med,1990,322:1689-1692.
8Vogelzang N,Breitbart W,Cella D,et al.For the fatigue coalition patient,caregiver,and oncologist perception of cancer-related fatigue:results of a tripart assessment survey[J].Semin Hematol,1997,34(3 Suppl 2):4-12.
9Groopman JE,Itri LM.Chemotherapy-induced anemia in adults:incidence and treatment[J].J Natl Cancer Inst.1999,91:1616-1634.
10Littlewood TJ,Bajetta E,Nortier JW,et al.Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy:Results of a randomized,double-blind,placebo-controlled trial[J].J Clin Oncol,2001,19:2865-2874.
6Tsukuda M,Yuyama S,Kohno H,et al.Effectiveness of weekly subcutaneous recombinant hum an erythropoietin adm inistration for chem otherapy-induced anemia. Biotherapy, 1998,11(1):21
7Abels RI ,Larbolt KM,Krantz, et al. Recombinant human reythropietin(HuEPO) for the treatment of the anemia of cancer;in Murphy MJ Jr(ed):blood cell growth factors:Their Present and future use in hematyology. Procceings of the Beijing Symposium. Dayton. Ohio,Alpha Med Press, 1991.121
8Cheung WK,Goon BL,Guilfoyle MC,et al.Pharmacokinetics and pharmacdynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. Clin Pharmaclo Ther, 1998,64(4):412
9[1]Tzeon-Jye Chiou.The Effect of Subcutaneous r-HuEPO in Cancer Patients Receiving Chemotherapy With Anemia:A Preliminary Report.Chin Med J,1997,60:229-235.
10[2]Henke M, Guttenberger R, Barke A, et al.Erythropoietin for patients undergoing radiotherapy:a pilot study.Radiother Oncol,1999,50:185-190.
